From November 1, 2022 to November 2, 2022, the company has repurchased 1,150,602 shares, representing 1.49% for ¥9,991.92 million. With this, the company has completed the repurchase of 1,150,602 shares, representing 1.49% for ¥9,991.92 million under the buyback announced on November 1, 2022.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
5,593 JPY | -0.37% | +0.68% | -17.63% |
Mar. 31 | A second Kobayashi Pharma Japan factory inspected over deaths | RE |
Mar. 30 | Kobayashi factory searched over deaths possibly linked to supplements | RE |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.63% | 2.72B | |
+10.96% | 381B | |
+1.66% | 120B | |
+11.49% | 72.81B | |
-15.18% | 63.83B | |
+0.76% | 53.41B | |
-11.15% | 37.09B | |
+2.14% | 32.95B | |
+5.76% | 17.08B | |
+7.21% | 14.47B |
- Stock Market
- Equities
- 4967 Stock
- News Kobayashi Pharmaceutical Co., Ltd.
- Tranche Update on Kobayashi Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on November 1, 2022.